risks of generic viagra buy cialis no prescription online cialis price buy discount cialis online discount generic viagra discount generic viagra buy cialis professional viagra superactive buy cialis cheap canada cialis buy now viagra

slide-01 slide-02 Screen4

Technology Platform

image-01

VaxInnate's Technology Platform is revolutionizing how vaccines are created and produced.

Explore

Product Pipeline

image-02

Learn more about our vaccines currently in our development pipeline

View

In The News

VAX2012Q

11 Nov 2014 - VaxInnate Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, Meets Phase 1 Seasonal Influenza Endpoints

- Top-Line Seroprotection Rates Exceed 90% in each of Four Vaccine Components; VAX2012Q to Proceed into Phase 2 Evaluation in 2015 – CRANBURY, NJ, November 11, 2014 – VaxInnate Corporation, a biotechnology firm pioneering next-generation vaccine technology, announced today that enrollment has concluded in the Phase 1 study of the Company’s experimental recombinant quadrivalent seasonal […]

Read